| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Yocca Frank is a Chief Scientific Officer at BioXcel Therapeutics, Inc.. Recent SEC Form 4 filings include 5 buys and 0 sells.
Estimated insider holdings value: $18K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2019 | BTAI Bioxcel Therapeutics, Inc. | Chief Scientific Officer | Buy | 6,547 | $8.67 | $56,762.49 | +353.9% | |
| Dec 4, 2018 | BTAI Bioxcel Therapeutics, Inc. | Chief Scientific Officer | Buy | 900 | $5.21 | $4,692.24 | +38.3% | |
| Nov 30, 2018 | BTAI Bioxcel Therapeutics, Inc. | Chief Scientific Officer | Buy | 450 | $5.20 | $2,339.55 | +90.0% | |
| Nov 29, 2018 | BTAI Bioxcel Therapeutics, Inc. | Chief Scientific Officer | Buy | 500 | $5.02 | $2,511.15 | New |